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EXECUTIVE SUMMARY

Polychlorinated biphenyls (PCBs) are a group of man-made chemicals associated with a
potential risk to human health and the environment. They were used in many building materials,
particularly caulking, grout, expansion joint material and paint, from approximately 1950 to 1978.
Both the U.S. Environmental Protection Agency (EPA) and the Agency for Toxic Substances
and Disease Registry (ATSDR) have published extensive material evaluating human health
impacts from exposure to PCBs. The apparent public health risks, including developmental
effects in children, reproductive effects and long-term risks for cancer development, have driven
consideration for actions, including further research into chronic health effects, mechanisms of
contact, and assessing actual and potential exposures, both in public and commercial buildings,
and in the workplace, where direct and incidental exposures may occur.
Two major legislative and legal efforts in the U.S. bring us to the current consideration of PCBs
as the next potential public health hazard abatement initiative. The Toxic Substances Control
Act of 1976 (TSCA), implemented restrictions and prohibitions regarding the manufacture, use
and disposal of PCBs in the U.S. The second involved legal action initiated by the New York
Lawyers for the Public Interest (NYLPI) after a concerned parent read a 2004 publication on
PCB investigations in Boston, Massachusetts schools and other buildings and subsequently
investigated his own child’s school. Currently, the EPA and the City of New York are working
together, under a Consent Agreement, to study and establish a policy for management of PCBs
in K-12 schools.
There is growing evidence that PCB exposures, in both vapor and particulate matter form,
emanate from PCB-containing products in the building environment. Additionally, secondary
sources of PCBs, including materials that have become contaminated due to absorption from
direct contact with PCB sources, or through adsorption of PCBs in the air that have been
emitted by primary sources, such as caulk or light ballasts, can contribute to the overall
exposures. In most cases, the building owners and occupants are not even aware of the
existence of these materials and their potential hazards. It is not clear what the risk from these
PCB-containing building materials is when compared to other PCB exposures (e.g. diet), due to
a lack of data on potential exposures from sources in the built environment.
The purpose of this white paper is to 1) provide an overview of currently available information
pertaining to PCBs in construction materials; 2) evaluate the exposure potential for building
occupants, maintenance and construction personnel; and 3) identify gaps in the current
knowledge base that would help occupational and environmental health professionals to better
understand the risk to public health from PCBs in building materials. AIHA’s findings and
recommendations will be updated as new information becomes available.
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ACRONYMS AND DEFINITIONS

ACGIH – American Conference of Governmental Industrial Hygienists.
AIHA – American Industrial Hygiene Association.
Aroclors – Trade name for various mixtures of chlorinated biphenyl congeners manufactured by
Monsanto Chemical Company which were sold in the United States. (See PCBs)
Aryl Hydrocarbon Receptor (AHR) – A cellular protein that is capable of binding to aryl
hydrocarbons, leading to changes in gene expression within the cell nucleus which can result in
abnormal cell function.
ATSDR – Agency for Toxic Substances and Disease Registry.
EPA – United States Environmental Protection Agency.
DOD – United States Department of Defense.
DOE – United States Department of Energy.
HEPA – High Efficiency Particulate Air. An air filter which can remove at least 99.97% of
airborne particles greater than 0.3 microns in size.
IARC – International Agency for Research on Cancer.
IRIS - Integrated Risk Information System.
Liquid PCBs – A homogeneous flowable material containing PCBs and no more than 0.5
percent by weight non-dissolved material.
LOAEL – Lowest Observed Adverse Effect Level. The lowest concentration of a chemical in a
study, or group of studies, that produces a statistically or biologically significant increase in
frequency or severity of adverse effects between the exposed population and an appropriate
control.
NIOSH – National Institute for Occupational Safety and Health.
NLPCBs – Non-liquid Polychlorinated Biphenyls. Materials containing PCBs that by visual
inspection do not flow at room temperature (25oC or 77oF) or from which no liquid passes when
a 100 gram or 100 milliliter representative sample is placed in a mesh number 60 +5 percent
paint filter and allowed to drain at room temperature for 5 minutes. (From 40 CFR 761.3)
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NOAEL – No Observed Adverse Effect Level. The highest concentration of a chemical in a
study, or group of studies, at which there is no statistically or biologically significant increase in
the frequency or severity of any adverse effects in the exposed population when compared to
an appropriate control.
Non-Legacy PCBs – Unintentionally produced PCBs that occur as trace contaminants in certain
products, particularly inks and dyes. Under TSCA, PCB concentrations of up to 50 ppm are
allowed in certain products as a result of manufacturing processes.
OSHA – Occupational Safety and Health Administration.
PCBs – Polychlorinated biphenyls. A group of compounds in which chlorine atoms replace the
hydrogen atoms in biphenyl. PCBs were used in industry in electrical insulators and in the
manufacture of plastics until 1979.
PCB bulk product waste - Waste derived from manufactured products containing PCBs in a
non-liquid state, at any concentration where the PCB concentration at the time of designation for
disposal is greater than or equal to 50 parts per million. In 2012, the EPA proposed that building
materials which have been “coated or serviced” with PCB-containing materials, such as caulk,
mastics or sealants, can also be handled as PCB bulk product waste.
PCB Congener – Any single, unique well-defined chemical compound in the PCB category. The
name of a congener specifies the total number of chlorine substitutes and the position of each
chlorine. There are 209 separate PCB congeners based on the number and position of the
chlorine atoms on the biphenyl ring structure.
PCB Homolog – A subcategory of PCB congeners having equal numbers of chlorine
substituents. For example, tetrachlorobiphenyls are all PCB congeners with exactly 4 chlorine
substituents that may be in any arrangement. There are 9 different homologs.
PCB remediation waste – Waste that has become contaminated as a result of a spill, release or
other unauthorized disposal of PCBs. This includes environmental media, such as soil,
sediments, gravel, sewage and industrial sludge, rags and other debris generated as a result of
any PCB spill cleanup, as well as building materials (e.g., concrete, masonry).
PPE – Personal protective equipment.
RfD – Reference dose. A numerical estimate of a daily oral exposure to the human population,
including sensitive subgroups such as children, that is not likely to cause harmful effects during
a lifetime.
TLV® – Threshold Limit Value.
TSCA – Toxic Substances Control Act.
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Unauthorized use – As per EPA TSCA regulations, any open applications (i.e., caulk) which
contain PCBs greater than or equal to 50 parts per million by weight are considered an
“unauthorized use” of non-liquid PCBs and requires removal of that material.
3.0

INTRODUCTION

Polychlorinated biphenyls (PCBs) are a group of man-made chemicals associated with risks to
human health and the environment.[1,2] PCBs were manufactured in the United States from the
late 1920s until 1979 for use in a variety of products including electrical equipment, hydraulic
fluids, inks, lubricants, flame retardants, adhesives, surface coatings, insulating materials,
pesticides, dyes, paints and plasticizers.[1,2,3,4,5] In the United States, TSCA promulgated a
prohibition on the manufacture of PCBs, which became effective in 1979.[4,5]
In the past, PCB exposures were thought to occur primarily in industrial and commercial settings
where transformers, capacitors or other electrical equipment containing PCB fluids were
located.[ 6 ] Growing evidence suggests that PCBs in construction materials may pose a
previously unrecognized risk to building occupants, maintenance staff and those working in
construction trades.[7] Building materials including caulking, adhesives, surface coatings, paint,
ceiling tiles, window glazing, light ballasts and electrical wiring have been reported by various
investigators inside and outside the United States to contain PCBs in the low parts per million
(ppm) to percent (by weight or volume) quantities.[8]
PCB exposures can occur in the built environment from direct contact, volatilization,
deterioration, or disturbance of PCB-containing materials. Children may be at particular risk due
to epidemiological evidence that PCBs are developmental toxins, and the fact that many of the
school buildings currently in use were either built or renovated during the time period that PCBs
were in use.[2,6,7,8,9,10]
The potential public health implications from exposure to PCBs in construction materials are not
well understood at this time. The evaluation of potential sources, pathways of human exposure
and the collective health risk should assist the industrial hygienist in the selection of appropriate
methods to control the exposure. Industrial hygienists are uniquely qualified to assist in the
evaluation of this emerging issue and can apply the principles of industrial hygiene (i.e.,
anticipation, recognition, evaluation, control and confirmation) to PCBs in the built environment
in order to reduce potential health risks for building occupants, maintenance staff and
construction workers.
The purpose of this document is to provide an overview of the available science and information
pertaining to PCBs in construction materials, to evaluate the PCB exposure potentials for
building occupants, maintenance and construction personnel, and to identify critical information
gaps that need to be addressed. This document also provides the user with background
information on PCB production, uses and toxicity.
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BACKGROUND

Polychlorinated biphenyls are a group of synthetic aromatic chemical compounds that have
between one and ten chlorine atoms attached to a biphenyl ring structure.[1,2,6] There are 209
separate PCB congeners, based on the number and position of the chlorine atoms on the
biphenyl ring structure.[1,2,6,11] Please refer to Appendix A for a table of the various PCB
species by congener number.
PCBs exist in a variety of physical states ranging from oily, viscous liquids to waxy solids that
are colorless to light yellow.[2,11] PCB chemical and physical properties include a high dielectric
constant, high solubility in hydrocarbons, very low solubility in water, thermal stability, low vapor
pressure, resistance to acids and bases, and chemical inertness under most
circumstances.[1,2,6,12] The physical properties, however, vary with degree of chlorination,
such that those congeners with fewer chlorine atoms are both more water soluble and more
volatile than those with more chlorine atoms. These properties make PCBs, particularly the
more highly chlorinated congeners, extremely persistent in the environment once
released.[1,2,12,13] This persistence of PCBs, coupled with their distribution through the food
chain, has resulted in continuing human uptake and exposure.
PCBs were manufactured in the United States from the late 1920s to approximately 1979.[1,2]
PCB production was also reported in Austria, China, Czechoslovakia, France, Germany, Italy,
Japan, the former Soviet Union, Spain and the United Kingdom.[1,2,6] Commercially produced
PCB products in countries outside the U.S. include the trade names Clophen (Germany),
Kanechlor and Sanotherm (Japan), Phenoclor (France) and Fenclor (Italy).[1,2,6]
In the U.S., approximately 99 percent of all PCBs were manufactured by the Monsanto
Chemical Company in Anniston, Alabama and Sauget, Illinois under the trade names Aroclor,
Therminol, and Askarel.[1,2,6] Peak production of PCBs in the United States occurred in 1970
with a reported production volume of 85 million pounds of Aroclors.[2,6] Reportedly, only
approximately 130 of the 209 congeners were used in commercial production of PCBs.[1]
Commercial PCB products were manufactured as a mixture of various PCB congeners, some of
which could include 50 or more congeners.[1,2,6,11] PCBs were manufactured through
progressive chlorination of biphenyls using anhydrous chlorine and iron filings or ferric chloride
catalysts.[6] Common trace impurities include chlorinated naphthalenes and chlorinated
dibenzofurans, which may play a role in the observed toxicity of PCBs.[1,2,6,11] From 1929 to
1971, Monsanto produced eight separate Aroclors (1221, 1232, 1242, 1248, 1254, 1260, 1262
and 1268).[2] After 1971, Monsanto voluntarily restricted production to Aroclor 1016, 1242, 1254
and 1221.[2]
Due to their unique chemical and physical properties, PCBs were used in a variety of
commercial products. The commercial products are categorized into three basic types: closed
applications, partially closed applications and open applications.[1,6]
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Closed applications include use as dielectric fluids in:
 transformers,
 capacitors,
 microwave ovens,
 air conditioners,
 fluid-cooled electric motors, and
 electrical light ballasts and fluid-cooled electromagnets.[1,2,6]
Partially closed applications include use in:
 hydraulic fluids,
 heat transfer fluids,
 switches,
 voltage regulators,
 circuit breakers,
 vacuum pumps, and
 electrical cables.[1,2,6]
Open applications include use in:
 inks,
 lubricants,
 waxes,
 flame retardants,
 adhesives,
 electrical and thermal insulating materials,
 pesticides,
 dyes,
 paints and other surface coatings,
 asphalt, and
 caulks and sealants (e.g. as plasticizers).[1,2,6]
At peak production in 1970, approximately 56 percent of PCBs were produced for use in closed
applications, 30 percent in use in open applications, such as plasticizers, and 12 percent in use
as hydraulic fluids and lubricants.[1,6] Aroclors manufactured by Monsanto were identified using
a standardized four-digit numbering system, where the first two digits indicate the type of
mixture and the last two digits indicate the approximate chlorine content, although there were
exceptions to the naming convention (e.g. Aroclor 1016 which contains mono- through
hexachlorinated homologs with an average chlorine content of 41 percent).[1,2,11]
During their period of production, PCBs entered the environment from a number of different
pathways, including accidental spills, leaks, fires, land disposal of PCB-containing products, and
manufacturing processes and wastes.[1,2,13] PCBs are still entering the environment today
through runoff from urban areas where PCB-containing buildings are prevalent, as well as
improper land disposal of PCB-containing products and the resulting leachate from hazardous
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waste sites where PCBs are not properly contained.[2,13,14] PCB contamination can be taken
up by small organisms such as plankton and invertebrates in marine and fresh water
environments.[1,2,13] The smaller organisms are then consumed by larger organisms, which
can lead to bioaccumulation, where the highest concentrations of PCBs are found in animals at
the top of the food chain, such as mammals, including humans.[1,2,13] While ingestion of
animal fats is the major route of human exposure, exposures can also occur from breathing air
contaminated with PCBs, drinking PCB-contaminated water or absorbing PCBs through the
skin. Additionally, animal studies suggest that PCBs are more readily absorbed via inhalation
than by ingestion.[15]
Evidence of PCB toxicity in humans first appeared as early as the late 1930s.[16,17] It was not
until the 1970s, however, that the U.S. Congress authorized the EPA to regulate PCBs due to
concerns, including PCB bioaccumulation and long-term persistence in the environment.[2,4,13]
The authority to regulate PCBs falls under TSCA, which implemented a number of restrictions
and prohibitions regarding the manufacture, use and disposal of PCBs in the United
States.[2,4,5,11,13] The goal of the TSCA regulation is the complete removal of PCBs as a
health risk, although this goal is based on hazard identification and not necessarily applied risk.
The TSCA regulations focused on liquid forms of PCBs (intact, predominantly in use as
dielectric fluids) and the consequences of spilled liquids to surfaces, substrates and soils. Other
downstream purchasers and consumers of manufactured PCBs were omitted from the
regulations. As a result, materials which are identified to contain PCBs greater than 50 ppm,
other than those allowances cited in the regulations (i.e., transformers), are considered an
“unauthorized use” of PCBs and must be removed.
In addition to the industrial and commercial sources of PCB pollution mentioned above, there is
now growing evidence that PCBs are entering the environment through PCB-containing
products in the built environment.[3,8,10,11,16,17,18,19,20] It has been estimated that over 154
million pounds of PCBs were sold in the United States between 1958 and 1971 for use in
various open-application products as listed above.[3] One study of buildings in Toronto, Canada
found that 27% of the non-residential buildings surveyed contain detectable quantities of PCBs
in sealants.[21] Published reports indicate that approximately 46% of all U.S. public and private
schools currently in use were constructed between 1958 and 1971. Many of these schools may
therefore have PCB-containing caulks, paints, adhesives and other open-application
products.[3]
Published studies indicate that airborne PCBs in concentrations exceeding EPA recommended
public health guidelines can be present in buildings with PCB-containing components and
construction materials.[3,18,19,20, 22 ] The nature and extent of the release of PCBs from
construction materials within the built environment is not well understood at this time. One
limited study found that teachers working in buildings with PCBs had higher serum PCB levels
when compared to a similar population that did not work in buildings with PCBs.[23] Given the
apparent widespread use of PCBs in construction materials, it appears that PCBs in the built
environment may be an underestimated public health risk for building occupants. Further
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research is needed to help determine the role that construction materials may have in the
exposure of building occupants to PCBs.
For the purposes of this white paper, the term “toxicity” is the inherent property of PCBs to
cause health consequences in humans; “exposure” is the sum of opportunities, through
inhalation, skin permeation, ingestion and/or injection, to deliver PCBs where they can affect the
human physiology; and “risk” is the probability of an adverse health effect and is dependent
upon the exposure dose and toxicity of the agent(s) of concern.
5.0

HEALTH EFFECTS

PCB exposures have been associated, both directly and indirectly, with a number of acute and
chronic health effects. Reported adverse health effects from PCB exposures include damage to
the hepatic, endocrine, dermal/ocular, immunological, neurological, and reproductive systems,
as well as cancer end points.[1,2,6,13] The reported health effects are based on studies of
community exposures from ingestion of contaminated foodstuffs, occupational exposures during
the manufacture of PCB mixtures (e.g. Aroclors) or PCB-containing components, and various
animal studies.[2,24,25] Determination of the mechanisms for the associated health effects is
complicated by a number of factors including the presence of other toxic contaminants from the
manufacturing process, such as chlorinated dibenzofurans (CDFs) within PCB mixtures, and
differences in the congener composition within commercially produced PCB mixtures compared
to the congener profiles that are found in the soil, air, water, or food chain months or even years
after release.[2,22,23] The presence of multiple PCB congeners and contaminants like CDFs,
which have the potential to exert similar toxic effects, make determination of the specific agents
responsible for a noted health effect difficult. [2,22,26] In addition, toxicity of PCB mixtures that
are released into the environment may change due to effects of volatilization and chemical or
biological transformation. [2,22,23,27]
Highly chlorinated PCB congeners have traditionally been thought to present a greater risk of
adverse health effects due to their persistence in the environment and ability to
bioaccumulate.[2,22,23,25,28] Highly chlorinated PCB congeners tend to be less volatile, less
water soluble, more likely to bind to sediment or soils and have higher bioaccumulation factors.
[22,23] Conversely, less chlorinated congeners tend to be more volatile, more water soluble and
more easily metabolized in animals.[22,23] However, while lower chlorinated congeners do not
bioaccumulate to the degree that the higher chlorinated congeners do, this does not mean they
do not cause adverse health effects. This is a particularly important consideration when
exposure to lower chlorinated congeners is via inhalation, which occurs almost continuously
when an individual in an indoor environment with PCB-containing materials present, but which is
not reflected as clearly by measurement of blood concentrations due to the short half-lives of
those congeners.
Of the 209 PCB congeners, 12 have been categorized as “dioxin-like” and have been assigned
toxic equivalency factors (TEFs) due to their ability to act upon the aryl hydrocarbon receptor
(AHR) and cause toxic effects similar to those caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
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[2,23,26, 29 ] Of the 12 dioxin-like PCB congeners, four are non-ortho substituted PCBs
(congeners 77, 81, 126 and 169) and eight are mono-ortho substituted PCBs (congeners 105,
114, 118, 123, 156, 157, 167 and 189).[23,26,27] The remaining 197 PCB congeners are
sometimes referred to as “non-coplanar” or “non-dioxin like” congeners.[23] These non-dioxinlike congeners are thought to exert toxic effects through multiple non-AHR mediated
pathways.[23]
5.1

Hepatic Effects

Animal studies indicate that PCBs are capable of causing hepatic damage, including
microsomal enzyme induction, liver enlargement, increased liver enzymes, fatty lesions,
necrosis and tumors.[1,2,6,13] Studies of humans with high concentrations of PCBs in their
blood have revealed the presence of abnormal liver indices such as cholesterol, liver enzymes
and lipids.[2] PCBs are known to induce a great variety of gene expression, by both AHR and
non-AHR-dependent mechanisms.[ 30 ] Human hepatotoxicity from PCBs, however, is not
conclusive due to limitations including study designs, lack of controls, susceptibility differences
among species and other confounding variables.[2]
5.2

Endocrine Effects

Evidence of direct endocrine effects from PCB exposures in humans is limited.[2] High
exposures to PCBs in humans have been associated with goiter (enlargement of the thyroid
gland).[2] Animal studies in rodents and non-human primates indicate that exposures to PCBs
in utero and in early development (e.g. breast feeding) can deplete circulating levels of thyroid
hormones and lead to hypothyroidism.[2]
5.3

Dermal and Ocular Effects

Dermal and ocular effects from PCB exposures in humans are well documented among
occupational and community PCB exposure groups, the latter through accidental ingestion of
PCB-contaminated food.[2,6,13] These effects include chloracne, pigmentation of the skin and
nails, excessive eye discharge, swelling of the eyelids, distinctive hair follicles and edema of the
hands and face.[2,6]
5.4

Immunological Effects

Immunological effects have been associated with PCB exposures in humans.[1,2] The strongest
evidence of such effects is based on studies of communities that consumed PCB-contaminated
food.[2] Increased susceptibility to infection was reported, although interpretation of the data
was hampered due to the presence of multiple other persistent organic pollutants.[2] Animal
studies indicate an association between high PCB exposures and morphological and functional
changes in the immune system.[2]
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Neurological Effects

Neurological effects have been associated with PCB exposures in humans.[1,2] The primary
evidence is based on epidemiological studies of communities that consume fish with high PCB
concentrations.[2] Abnormal reflexes, memory, learning and IQ have been reported as
neurologic outcomes associated with the PCB exposures. Human exposure studies have
identified associations between behavioral effects and highly chlorinated congeners, while
animal studies have shown an association between PCB exposures and central nervous system
effects and have linked dioxin-like and non dioxin-like congeners to neurological effects.[2]
5.6

Reproductive Effects

Reproductive effects from PCB exposures have been reported, but human data are limited.
[1,2,13] Animal studies in rodents and monkeys indicated that PCB exposures may be
associated with menstrual changes.[2] Confounding variables in humans, however, make
confirmation of similar menstrual disturbances, as well as effects on sperm morphology and
production, difficult.[2]
5.7

Developmental Effects

Developmental effects have been associated with PCB exposures in animals and human
studies.[2] Animal studies have linked PCB exposures in utero and during early development
with hypothyroidism.[2] Thyroid deficiencies during fetal and neonatal development in humans
can lead to auditory, motor and intellectual deficiencies.[2] A number of studies have associated
developmental effects, including cognitive and motor skill deficiencies, delayed development,
and behavioral problems, in children born to mothers who were exposed to PCBs and
polychlorinated dibenzofurans (PCDFs) from eating contaminated food in Japan and
Taiwan.[2, 31 , 32 , 33 , 34 , 35 ] Other studies have found associations with behavioral and
intelligence deficits among children whose mothers were exposed to PCBs from eating
contaminated food.[2,36,37,38,39,40,41,42] Prenatal PCB exposures have been associated
with low birth weight, smaller head circumference and shorter gestational age in newborns,
although the evidence is not conclusive. [2,34]
5.8

Cancer

Evidence of the association between PCBs and cancer in humans is supported by both
retrospective epidemiological studies of workers exposed during manufacturing and repair of
capacitors, and case-control studies of the general population, which looked at associations
between adipose PCB concentrations and cancer.[1,2] These studies indicate an association
between PCB exposures and cancers of the liver, biliary tract, intestines and melanoma.[2] In
the late 1980s, the International Agency for Research on Cancer (IARC), the U.S. EPA and the
National Toxicity Program (NTP) all classified PCBs as probable human carcinogens (IARC
Group 2A) based on extensive evidence in animal studies.[1,2] The American Conference of
Governmental Industrial Hygienists (ACGIH) did the same in 1996. Finally, the U.S. Department
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of Health and Human Services (HHS) Agency for Toxic Substances and Disease Registry
(ATSDR) addressed PCB carcinogenicity in 2000 and its addendum, issued in April 2011,
added reference studies noting non-Hodgkins lymphoma and prostate cancer risks.[43]
IARC recently revisited the issue of carcinogenicity of PCBs and has declared all PCBs to be
Group 1, known human carcinogens, based on strong evidence for exposure increasing the risk
of malignant melanoma, with less strong evidence for breast cancer and non-Hodgkins
lymphoma.[44] Other cancers have also been reported to be increased in relation to PCB
exposure, but overall evidence is limited.
5.9

Diabetes, Cardiovascular Disease and Hypertension

There is increasing evidence that the major chronic diseases of older age, including diabetes,
cardiovascular disease and hypertension, but excluding cancer, are also associated with
exposure to PCBs and other persistent organics, including dioxins and chlorinated
pesticides.[45,46] Because these chemicals are all lipophilic and found in body fat, it is difficult
to identify which chemical is responsible for the associations with these diseases. The exception
is hypertension, which is strongly associated with serum PCBs levels but unrelated to
concentrations of pesticides.[47]
6.0

EXPOSURE EVALUATIONS

6.1

Exposure Assessment

The nature of the complete exposure profile from PCB-containing materials for building
occupants and for the occupationally exposed is a complex one. Exposures to PCBs in the built
environment can occur via inhalation of PCB vapors and contaminated particulates, as well as
via ingestion and dermal pathways. The determination of the predominant pathways is key to
controlling any potential exposures. Consideration should be given for modeling and then
validating (through confirmatory sampling) the possible exposure pathways. Identification of the
specific PCB congeners present should be considered, as the current literature suggests that
lower molecular weight PCBs are more likely to be released before the higher molecular weight
PCBs.
6.2

Exposure Pathways

6.2.1

Inhalation

The inhalation pathway for exposure to PCBs includes both vapor and particulate exposures.
Depending upon the nature of occupancy and activities occurring within the building, the
inhalation pathway may be dominated by either of the physical forms, or the contributions may
be equal. The release of PCBs into the built environment is largely dependent on the condition
of the PCB-containing materials, presence (or absence) of impermeable coatings, air
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temperature, ventilation dynamics and air flow rates. All of these factors must be taken into
consideration when considering potential inhalation exposure pathways.
6.2.1.1

Vapor Exposure Contribution

Vapor exposure can occur from virtually any PCB-containing materials within a room or building.
The predominant potential sources are failed fluorescent light fixture ballasts. These are,
however, typically discrete, episodic exposures that are usually easily identified by failure of the
light fixture. Of a more chronic nature is the vapor release of PCBs from caulking, as well as
from other building materials that have absorbed PCBs over time and then subsequently rerelease them into the indoor environment. One study found a sum of 440 nanograms per cubic
meter of air (ng/m3) of six PCB congeners in indoor air of a building constructed in 1969 of
prefabricated concrete panels and sulfur-based caulk (Thiokols).[48] Other PCB sources within
the building, however, could not be ruled out. Another study reported airborne PCB levels of 610
micrograms per cubic meter of air (µg/m3) in inhabited apartments prior to testing various
abatement methods.[49]
During an initial assessment of airborne concentrations in school systems in Massachusetts,
researchers detected Aroclor 1254 at concentrations ranging from 111 to 393 ng/m3.[ 50 ]
Swedish researchers investigating biomarkers of exposure found that higher chlorinated PCB
mixtures (Aroclor 1248, 1254 or 1260) were used in the manufacture of caulks, but that lower
chlorinated PCB congeners (mainly PCBs 28, 52 and 66) were present in the air samples due to
their higher volatility.[51]
During testing of the efficacy of a variety of intervention methods at a school, researchers
reported an initial mean indoor air total PCB concentration of 533 ng/m3.[3] The authors
reported that by increasing outdoor air ventilation, encapsulating the caulk, and constructing a
physical barrier over the encapsulated material, they were able to reduce indoor airborne PCB
concentrations to a mean value of 76 ng/m3.
6.2.1.2

Particulate Exposures Contribution

Exposure to PCB-containing particulates is more likely to pose an inhalation risk to construction
workers and remediation contractors than is exposure to PCB vapors, due to the generation of
particulates during the dismantlement of structures and gross removal of PCB caulk and other
materials. A number of studies have examined airborne exposures during these types of
activities.
Swedish researchers examined determining factors for controlling PCB exposures during the
cleanup of PCB-containing sealants. A variety of methods and control sets were utilized, which
resulted in worker breathing zone PCB concentrations ranging from 5.5 µg/m3 to 120 µg/m3.[49]
Finnish researchers studied workers during a national abatement effort.[52] Both particulate and
vapor phase samples for seven different PCB congeners (28, 52, 77, 101, 138, 153 and 180)
were collected. No differentiation of the relative contributions of the various congeners,
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however, was made. Reported airborne concentrations ranged from none detected to 3.1
µg/m3.[52]
From the variety of studies in the literature, it is clear that source identification and selection of
PCB congeners for characterization is important when assessing the exposure opportunities to
both public occupants and potential construction or maintenance forces.
6.2.2

Ingestion

Ingestion pathways are a consideration for both public and occupational exposures. When
establishing the collective risk of PCBs in a structure, the behaviors of the occupants must be
understood and taken into account. Small children are more likely to have ingestion pathway
opportunities than older children, based simply on hand-to-mouth behavior. However, personal
hygiene habits may also lead to ingestion paths for both older children in public exposures and
workers in occupational exposures. Mapping of all occupants and their opportunities for coming
into contact and possibly ingesting PCB-bearing particulates and settled dust is necessary for
understanding this contribution to a total exposure determination.
6.2.3

Dermal

Skin notations exist in the ACGIH documentation for PCB 1242 based on reported fatty
degeneration of the liver following dermal application to animals, and for PCB 1254 based on
liver toxicity reported among animals treated dermally.[53] The designation of a “skin” notation
indicates that there is the potential for significant contribution to the overall exposure by the
cutaneous route, including mucous membranes and the eyes, through contact with vapors,
liquids, and/or solids. Where dermal application studies have demonstrated that absorption
could cause systemic effects following exposure, a skin notation would be considered.[54]
6.2.4

Injection

Injection exposures have not been identified in the literature as a potential pathway for PCB
exposures.
6.3

Biomonitoring

Cumulative past exposure to PCBs can generally be determined through measurement of
serum PCB levels. Adult age-related accumulations of non-dioxin-like PCBs have been
observed in a number of studies.[55,56,57] Such studies can provide physicians and public
health officials with reference values with which to determine whether or not individuals have
been exposed to higher levels of PCBs than those found in the general population. Many PCBs
can remain in the body for years after exposure, though some of the lower chlorinated PCB
congeners have relatively short residence times.[ 58 ] Concentrations of individual PCB
congeners in the body will vary with the exposure source(s) and differences in pharmacokinetics
(i.e., congeners with longer half-lives will accumulate to higher levels within the body). Serum
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concentrations of the di-ortho-substituted PCBs are typically higher than concentrations of the
mono-ortho-substituted PCBs which, in turn, are greater than the coplanar PCBs.[57,58,59,60]
Non-dioxin-like PCBs 138, 153 and 180 are the most frequently detected di-ortho-substituted
PCBs reported in population studies and typically account for a substantial portion of total
measured PCBs.[57,58,61,62]
7.0

REGULATIONS

7.1

Toxic Substances Control Act

In the U.S., PCBs are regulated under TSCA, which was enacted by Congress in October 1976.
The regulations are designed to protect public health and the environment from toxic chemicals,
and those related to PCBs are codified in code of Federal Regulations, under 40 CFR 761,
which includes regulations on the manufacture, processing, importation, distribution, use and
disposal of PCBs. TSCA first established a ban on production of PCBs effective July 1979, with
distribution in commerce banned after 1984. The regulation then established management
policies for those materials that had already been produced prior to the ban.
There is currently no requirement for a building owner or property manager to conduct air or
bulk sampling to determine if PCBs are present in, or released from, building materials. The
TSCA regulations do require that materials which may contain PCBs be characterized to ensure
proper disposal if PCB wastes will be generated. This means that PCBs in the built environment
may be identified during routine sampling of waste streams that will be generated during
building renovation or demolition activities.
If PCB-containing building materials are identified within a building or in the surrounding soils,
specific actions are required based on the following criteria:
1. Concentration of PCBs present in the identified building material;
2. Classification of identified materials as either “PCB bulk product waste” or “PCB
remediation waste”;
3. Location of the PCB-containing materials; and
4. Extent of any additional contamination that may have occurred to surrounding or
adjacent building materials.
Some of the key provisions of the TSCA rules that relate to PCBs in the built environment are
summarized below.


Subpart A – General:
o Defines the applicability of the rule, PCB concentration assumptions for use and
definitions.
o Defines “PCB bulk product waste” as waste derived from manufactured products
containing PCBs in a non-liquid state, at any concentration in which the
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concentration at the time of designation for disposal was greater than or equal to
50 ppm PCBs. PCB bulk product waste includes, but is not limited to:
 Non-liquid bulk waste or debris from the demolition of buildings and other
man-made structures manufactured, coated, or serviced with PCBs. PCB
bulk product waste does not include debris from the demolition of
buildings or other man-made structures that is contaminated by spills
from regulated PCBs that have not been disposed of, decontaminated, or
otherwise cleaned up in accordance with subpart D of this part.
 PCB-containing wastes from the shredding of automobiles, household
appliances, or industrial appliances.
 Plastics (such as plastic insulation from wire or cable; radio, television
and computer casings; vehicle parts; or furniture laminates); preformed or
molded rubber parts and components; applied dried paints, varnishes,
waxes or other similar coatings or sealants; caulking; adhesives; paper;
Galbestos; sound deadening or other types of insulation; and felt or fabric
products such as gaskets.
 Fluorescent light ballasts containing PCBs in the potting material.
o

Defines “PCB remediation waste” as waste containing PCBs as a result of a spill,
release, or other unauthorized disposal, at the following concentrations: Materials
disposed of prior to April 18, 1978, that are currently at concentrations ≥ 50 ppm
PCBs, regardless of the concentration of the original spill; materials that are
currently at any volume or concentration in which the original source was ≥ 500
ppm PCBs beginning on April 18, 1978, or ≥ 50 ppm PCBs beginning on July 2,
1979; and materials that are currently at any concentration if the PCBs are spilled
or released from a source not authorized for use under this part. PCB
remediation waste means soil, rags, and other debris generated as a result of
any PCB spill cleanup, including, but not limited to:
 Environmental media containing PCBs, such as soil and gravel; dredged
materials, such as sediments, settled sediment fines, and aqueous
decantate from sediment.
 Sewage sludge containing < 50 ppm PCBs and not in use according to §
761.20(a)(4); PCB sewage sludge; commercial or industrial sludge
contaminated as the result of a spill of PCBs including sludge located in
or removed from any pollution control device; or aqueous decantate from
an industrial sludge.
 Buildings and other man-made structures (such as concrete floors, wood
floors, or walls contaminated from a leaking PCB or PCB-contaminated
transformer), porous surfaces, and non-porous surfaces.

o

Defines “Totally Enclosed Manner” as any manner that will ensure no exposure
of human beings or the environment to any concentration of PCBs.
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Subpart B – Manufacturing, Processing, Distribution in Commerce, and Use of PCBs
and PCB Items:
o Defines the prohibitions, exceptions, authorizations and storage requirements for
the use and reuse of PCBs.
o Bans the use of PCBs in anything but closed system applications.



Subpart C – Marking of PCBs and PCB Items
o Defines the marking and labeling of PCB-containing items.



Subpart D – Storage and Disposal
o Defines the storage and disposal requirements of PCBs
o Defines cleanup levels for porous surfaces, non-porous surfaces in both high and
low-occupancy areas.



Subpart G – PCB Spill Cleanup Policy
o Defines the requirements for cleanup of PCB spills



Subpart K – PCB Waste Disposal Records and Reports
o Defines the requirements related to waste disposal activities including EPA
identification numbers, notifications, waste manifests, retention of records and
exception reporting.



Subpart N – Cleanup Site Characterization Sampling for PCB Remediation Waste
o Defines the sampling of PCB bulk remediation waste, porous surfaces, nonporous surfaces, and liquid PCB samples.



Subpart O – Sampling to Verify Completion of Self-Implementing Cleanup and On-Site
Disposal of Bulk PCB Remediation Waste and Porous Surfaces.
o Defines the sampling methods including sample size, sample collection
procedures, compositing of samples, sample extraction and analysis and
reporting and record keeping of PCB concentrations in samples.
Department of Transportation

The Department of Transportation, under 49 CFR Part 172, designated PCBs as hazardous
materials and prescribes requirements for shipping papers, package marking, labeling, and
transport vehicle placarding applicable to the shipment and transportation of PCBs.
7.3

Comprehensive Environmental Response, Compensation and Liability Act

PCBs are designated as hazardous substances under section 102(a) of the Comprehensive
Environmental Response, Compensation and Liability Act of 1980 (CERCLA), as amended by
the Superfund Amendments and Reauthorization Act (SARA) and section 311(b)(2)(A) of the
Clean Water Act. The EPA has established a threshold reportable quantity of one pound for
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PCB mixtures. If a PCB release exceeds this threshold quantity, then the EPA must be notified
(40 CFR Part 302).
7.4

Emergency Planning and Community Right to Know Act

Under the Emergency Planning and Community Right to Know Act (EPCRA), which was an act
amending CERCLA, PCB releases are included in the Toxic Release Inventory (TRI) database
which is maintained by the EPA. The TRI database is publicly accessible and is intended to
inform the general public and communities surrounding covered facilities about releases of toxic
chemicals.
7.5

Occupational Exposure Limits

OSHA has established Permissible Exposure Limits (PELs) for two Aroclors that are expressed
as eight-hour time-weighted average (TWA) exposure concentrations. The PELs, which are
listed in 29 CFR 1910.1000, Table Z-1, are for chlorodiphenyl compounds containing 42 percent
(Aroclor 1242) and 54 percent chlorine (Aroclor 1254). The PELs are 1.0 milligram per cubic
meter of air (mg/m3) and 0.5 mg/m3, respectively, and both compounds have a “skin” notation,
designating that significant exposure may occur through the dermal route.
The National Institute for Occupational Safety and Health (NIOSH) has established a 10-hour
Recommended Exposure Limit (REL) of 0.001 mg/m3 for both Aroclor 1242 and 1254, and lists
both compounds as carcinogens.
The 2013 ACGIH Threshold Limit Values (TLVs) for Aroclor 1242 and 1254 are identical to the
OSHA PELs.[53,54]
7.6

Department of Energy

The Department of Energy (DOE) does not have any regulations that specifically address PCBs.
However, the DOE, through the Worker Safety and Health Program found in 10 CFR Part 851,
has codified the ACGIH TLVs for Aroclors 1242 and 1254. In addition, there is an expectation
for a comprehensive exposure assessment program that would imply an effort at hazard
identification.
8.0

RISK ASSESSMENT

8.1

Background

There are four basic steps in the risk assessment process, whether focused on human health or
toward environmental stressors. The steps include: 1) hazard identification, 2) dose-response
assessment, 3) exposure assessment, and 4) risk characterization. These four steps are
designed with the goal of formulating a detailed understanding of the potential severity and
scope of a hazard – in this case, the risk of PCB exposure in the built environment. This
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process is used by various U.S. government agencies, as well as some state, local and regional
agencies, and other countries when performing risk assessments. The risk assessment for
PCBs evaluates health impacts including both cancer and non-cancer end points. The hazard
identification and exposure assessment components of the risk assessment process have been
discussed in detail in section 6.1 of this document and are mentioned again briefly below to
clarify the risk characterization.
Exposed populations include building occupants (both adults and children), as well as
construction workers renovating buildings and removing PCB-containing materials.
Understanding the actual health risks will allow for cost-effective mitigation of PCB
materials from indoor environments. In addition, the identification of target concentrations of
PCBs in the indoor air will provide practitioners the values that can aid in the design and
performance evaluation of various abatement activities.
The current U.S. EPA-recommended levels for PCBs in indoor school air were set at varying
concentrations, based on the children’s age, ranging from 70 ng/m3 for 1-3 year olds to 600
ng/m3 for 15-19 year olds. The aim of these EPA levels was to keep children’s overall PCB
intake to below the reference dose of 20 ng PCB/kg-day. An example of international guidelines
for PCBs includes those established in Germany in 1995, which require the remediation of
buildings with elevated indoor air concentrations. The action limit for remediation was set at
3000 ng/m3, while tolerable PCB indoor air concentration was defined as 300 ng/m3. The aim of
the German guidelines is to reduce airborne PCB concentrations in all living environments to
below 300 ng/m3.[49]

Figure 1. Histogram of mean PCB congener pattern in indoor air in rooms with two different
PCB sources [63]
Figure 1 is an illustration of the concentrations of various congeners that were emitted into the
indoor air from two different PCB-containing products, Thiokol rubber sealant and flame
retardant coating on acoustic ceiling tiles. Clearly, the Thiokol sealant emitted greater levels of
PCB 28 and 52 congeners than did the flame retardant material. Conversely, the flame
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retardant material emitted higher levels of PCB 101, 138 and 153 congeners than did the
Thiokol sealant. The figure above illustrates one of the challenges in conducting a risk
assessment for PCBs, namely the uncertainty associated with an understanding of the source
materials and the mixture of congeners within, and emitted by, those sources.
Using the common four-step risk framework discussed above, the risks of exposure to PCBs
can be examined. However, the numbers must be considered a reference point for decisionmaking instead of a defining line between safe and unsafe. The exposures and dose-response
relationships used to conduct any risk assessment are products of research publications and,
while informative and thought provoking, the data are generally not appropriate for decisionmaking. Understanding the uncertainties of a risk assessment will provide decision makers and
stake holders the necessary information to take appropriate corrective actions.[64]
8.2

Hazard Identification

The U.S. EPA and ATSDR have published an extensive amount of material evaluating the
human health impacts from exposure to PCBs. A useful summary can be found on the EPA’s
Integrated Risk Information System (IRIS). Based on the weight of evidence in humans and
experimental animals, the IARC upgraded PCBs from Group 2A, probably carcinogenic to
humans, to Group 1, carcinogenic to humans in 2013.[44] More than 70 independent
epidemiological studies with data for carcinogenicity of PCBs in humans were considered.
Excess risks for melanoma were reported in several studies and a significant linear exposureresponse trend was noted in the largest study. The association between PCBs and melanoma
was consistently noted in different North American and European industries.[44] The weight of
the evidence is what will allow for the reduced uncertainty factors used to develop a Reference
Dose (RfD) or slope factor.
8.3

Dose Response

The EPA’s IRIS provides a detailed assessment of the toxicity of PCBs. Table 1 is a summary of
the information from the literature.
Table 1. Carcinogenicity data, Oral Exposure
Aroclor Type

Dose (ppm)

Human Equivalent
(mg/kg/day)

Tumor Incidence

Aroclor 1260

0
25
50
100

0
0.35
0.72
1.52

1/85
10/49
11/45
24/50

Aroclor 1254

0
25
50
100

0
0.35
0.76
1.59

1/85
19/45
28/49
28/49
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Aroclor Type

Dose (ppm)

Human Equivalent
(mg/kg/day)

Tumor Incidence

Aroclor 1242

0
50
100

0
0.75
1.53

1/85
11/49
15/45

Aroclor 1016

0
50
100
200

0
0.72
1.43
2.99

1/85
1/48
7/45
6/50

Reference – EPA IRIS for PCBs and Brunner et al., 1997 [65]

Slope factors are multiplied by lifetime average daily doses to estimate the cancer risk. PCB
exposures are often characterized in terms of Aroclors, but this manner of profiling PCBs may
not be precise as toxicity is linked more closely to specific congeners. Either central estimates
or upper bounds can be used as appropriate measures of risk. In general, the central estimates
describe an individual's risk, and the upper bounds provide a risk for a population. The EPA
IRIS published central slope factor and upper bound slope factor for PCBs are 1.0 and 2.0
(mg/kg)/day respectively for high risk persistence, while the slope factors for low risk and
persistent exposure are 0.3 and 0.4 (mg/kg)/day, respectively. The above slope factors are
generally used for ingestion of PCBs. The Unit Risk factor is often used for inhalation of
evaporated congeners, where the low risk and persistent exposure slope factor (0.3
(mg/kg)/day) is converted to a unit risk factor of 1 x 10-4 µg/m3.
EPA has also published RfDs for non-carcinogenic endpoints. Oral RfDs for Aroclor 1254 of 20
(ng/kg/day) and Aroclor 1016 of 70 (ng/kg) day have been published, where each RfD has an
uncertainty factor of 300. The uncertainty factor of 300 was established to compensate for
uncertainties when extrapolating data from a lowest observed adverse exposure level (LOAEL)
to a no-observed adverse exposure level (NOAEL). It is important to understand, however, that
PCB animal testing was conducted with the manufactured Aroclor material, and not with a
mixture of PCB congeners that are more persistent in the environment. This again provides an
uncertainty associated with the animal testing data and an understanding of human health
impacts. Children’s exposure presents an additional uncertainty in that there may be greaterthan-proportional effects from less-than-lifetime exposure, especially for persistent mixtures and
early-life exposures.
8.4

Exposure Assessment

As previously discussed in section 6.1, research into risk from airborne PCB exposures in
buildings has been conducted in the U.S. and other countries by numerous scientists. Exposure
data from a number of published studies is presented in Table 2.
While the data are limited for both airborne exposures and serum levels for a specific study, a
number of researchers have examined serum and airborne PCB concentrations at different
times. Researchers studied the serum levels of six U.S. construction workers involved in
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removing PCB-containing caulk. The workers were found to have statistically higher serum PCB
levels than the reference population for specific congeners, namely PCBs 6, 16, 26, 32, 36, 41,
70, 97 and 136.[66] The reported findings were similar to the results of studies previously done
in both Finland and Sweden.[51,52] It should be noted, however, that the U.S. study quantified
57 congeners, as compared to 24 congeners in the Finnish study and 19 congeners in the
Swedish study.
Table 2. Summary of select airborne exposures to PCBs from caulking/sealant

Location

PCB Source

Total PCB Exposure
(ng/m3)
Mean

Min

Max

350

780

95
CI

Reference for the
Exposures

School

Window Caulk

533

Office Building

Window Caulk

1740

School

Window Caulk

2.4

30

Sullivan, 2008 [68]

University
Office Building

Caulk, Gaskets,
Foamboard Insulation

111

393

Coughlan, 2002 [50]

Worker Construction
Office
Buildings

Expansion Joint
Removal with LEV*

600

Sundahl, 1999 [49]

Joints and Window

45

Hazarati, 2006 [69]

Office
Buildings

Sealants & Flame
Retardants

715

4280

715

2253

MacIntosh, 2012 [3]
3740

Schettegen, 2012 [67]

Heinzow, 2004 [63]

*LEV – local exhaust ventilation

8.5

Risk Characterization

In risk characterization, the hazard quotient and cancer risk for exposure to PCBs can be
calculated. The Hazard Quotient (HQ) is a scaling factor and is not statistically based. If the HQ
is greater than 1, then there may be an increased risk, while an HQ below 1.0 suggests no
concerns for adverse health effects are present. The excess lifetime cancer risk is an
incremental probability of the exposed persons developing cancer over a lifetime. Using the
information from the ATSDR and IRIS for PCBs, along with published exposure levels, one can
estimate the cancer risks and Hazard Quotients. However, as with all risk assessments, the
calculated numbers must be viewed in the light of the multitude of uncertainties. As an example,
if one considers only the variability in the exposures for building occupants, and keeps all the
other variables constant, the cancer risks range over two orders of magnitude from 4/1000 to
4.5/100,000. However, the non-cancer risk is significantly below unity for building occupants and
workers from the published exposure data, although there are reasons to question whether the
non-cancer risks have been adequately identified.
Hazard Quotient (HQ) = Chronic Daily Intake/RfD
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Cancer Risk = Chronic Daily Intake x Slope factor or Unit Risk Factor
Of greater interest for those concerned with the health of workers, building occupants and
school children is the paucity of data with respect to the exposure to specific congeners. Several
different studies have shown increased serum PCB levels among construction workers when
compared to control groups. These studies examined the ratio of light to heavy congeners to
understand the source of PCB exposure.[51,52,66] In a comparison of congener profiles for
PCB 6 to 74, one study found that the control group values for lighter congeners did not exceed
those of the construction workers.[46] Researchers in a 2006 study proposed that a set of
marker PCB congeners – specifically PCBs 44, 56, 60, 66, 70, 110, 153 and 180 - be used to
track occupational exposures. Their general conclusion was that the traditional set of serum
markers used to measure PCB exposures (PCBs 28, 52, 101, 101, 118, 138, 153 and 180)
were not well suited for identifying occupational exposures.[51] While there are relatively few
studies linking PCB congener airborne concentrations to PCB serum congener levels for the
same set of workers, the limited results have observed a relationship between occupational
exposure and serum levels. However, the limited number of studies and the varying number of
congeners evaluated by each of those studies does result in a significant uncertainty within the
risk assessment process.
While only limited congener-specific airborne data are available, protective measures have been
shown to reduce worker exposures. Two recent studies identified a series of control measures
to protect workers and building occupants.[3,70] Reductions in airborne levels of PCBs and
reduced PCB serum levels over time were observed even though individuals continued working
as PCB abatement workers.
9.0

IDENTIFICATION AND EVALUATION OF PCBs IN BUILDINGS

9.1

Inspection and Material Testing

As noted above, buildings constructed, renovated and/or repaired between 1950 and 1978 are
likely to contain a variety of building materials containing PCBs.[5] To assess if building
materials contain PCBs, bulk samples must be collected and analyzed. Analysis should be
done by an environmental laboratory that is certified to analyze such samples. Additionally,
PCBs from caulking, mastics, paint and other coatings are often absorbed into the porous
building materials on which they were applied.[71] As a result, significant levels of PCBs can
migrate into adjacent materials and be present several inches deep into adjacent wood,
concrete, cinder block, brick or masonry. Additionally, PCBs from exterior caulks, sealants and
paints can migrate into and contaminate surrounding soil as a result of natural weathering.
Accordingly, sampling of any exposed soil around the perimeter of the building may also be
warranted.
Assessment and sampling must be done correctly and the building occupants must be protected
from excessive exposure to PCBs during those activities. For this reason, inspection and
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sample collection are usually done off hours or on weekends when building occupants are not
present. Some materials, like caulking, may also contain other regulated contaminants, such as
asbestos or lead, in addition to PCBs. Therefore, assessment protocols and methodologies
similar to those used for these materials can be used as a template. While there are no
nationally recognized PCB inspector certifications, facility owners may want to consider using
inspectors accredited under the EPA Asbestos Hazard Emergency Response Act (AHERA) or
Lead-Based Paint Renovation, Repair and Painting (RRP) certification programs. All individuals
should also have PCB awareness training.
Training for individuals who will be collecting samples should include the following:









Hazard Communication training for PCBs that, at a minimum, meets the requirements of
29 CFR 1910.1200;
The importance of safe work practices to minimize the release of, and exposure to,
potential PCB materials during sample collection;
Information on other hazardous materials (e.g. lead, asbestos) that may also be present;
Materials that should be suspected to contain PCBs, including surrounding materials
that PCBs may have migrated to over time;
Sample collection methodology, including information on collecting sufficient quantity for
analysis, proper storage containers, utilizing sampling techniques that minimize release
of PCBs into the environment;
Proper use of PPE per the manufacturers’ user instructions; and,
Instructions that eating, drinking and smoking are prohibited during sample collection
and not allowed until mandatory hand and face washing has been completed

Additional information on sampling building materials for PCBs is available on the U.S. EPA
website.
As previously mentioned, TSCA considers materials containing greater than 50 ppm PCBs to be
an unauthorized use of PCBs and such materials must be removed.[4] There is no requirement
under current federal regulations, however, for building owners to perform sampling for PCBs in
building materials. Currently, the EPA recommends conducting preliminary air testing in school
buildings to determine airborne PCB levels prior to deciding whether or not to inspect for PCBcontaining building materials, although again there is no legal obligation to do so.
Prior to performing an inspection, construction records (if available) should be reviewed to help
identify suspect materials and possible PCB-containing equipment (e.g., transformers, light
ballasts and heat transfer systems). Sampling of caulking and other suspect materials should
include a visual assessment for different ages and types of applications, homogeneity of
materials, applicability and use of the products, the condition of the materials and other field
observations. Additionally, the potential for human exposure to materials (i.e., accessibility,
frequency and duration of contact) should be determined and noted.
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When performing bulk material or soil sampling, disposable sampling tools should be utilized
and discarded after each sample in order to avoid cross contamination. Alternatively, stainless
steel sampling instruments may be used but must be properly decontaminated between
samples. Sampling of adjacent porous building materials, such as concrete or masonry, is more
labor-intensive and requires core sampling in order to identify how deeply the PCBs have been
absorbed. Core sampling involves drilling into the substrate material and collecting the dust or
debris that is generated. Proper decontamination of the drill bits and equipment between
samples is essential.
Analysis of bulk material samples for PCBs is typically performed via EPA Method 8082A using
gas chromatography (GC). The method can be used to determine concentrations of either
Aroclors or as certain individual congeners (the method can only detect 19 of the 209 PCB
congeners). Alternately, a high-resolution gas chromatography/high resolution mass
spectrometry (GC/MS) method, such as EPA Method 1668B, can be used to quantify individual
PCB congeners, although such methods can be quite costly to perform. In addition to PCBs, the
sampled materials should also be assessed for other possible contaminants (i.e., asbestos and
lead).
Surface wipe sampling may also be performed to assess visual staining of surfaces from liquid
PCB sources and dust accumulation from deteriorated building materials in accordance with
EPA Method SW-846-8082 as described in 40 CFR 761.123 and 761.130.
Personal protective equipment (PPE) used during sample collection will depend on the material
being sampled and its condition. Intact items like light fixture ballasts, or soft, pliable caulking,
will likely not require any PPE other than chemical protective gloves, such as nitrile, to minimize
skin contact and American National Standards Institute (ANSI) Z87.1-compliant eye protection.
The glove manufacturer should be consulted for suitability of the glove for incidental contact with
PCBs. If the suspect PCB-containing material is friable (e.g. dry, brittle caulk), will be
mechanically disturbed (e.g. concrete drilling) or is leaking (e.g. ballasts, transformers),
respiratory protection may also be required. Depending on the condition of the material and the
extent of sampling required, task-specific PPE may be required.
10.0

AIR MONITORING

For determining the presence of PCBs in indoor air, the EPA currently has two approved
methods: Compendium of Methods for the Determination of Toxic Organic Compounds in
Ambient Air – Compendium Method TO-4A (high air volume); and Compendium Method TO10A (low air volume).[72,73] Both methods utilize sorbent cartridges containing pre-cleaned
open-cell polyurethane foam (PUF) as the sampling media, and analysis by GC coupled with an
electron capture detector (ECD), nitrogen-phosphorus detector (NPD), flame photometric
detector (FPD), Hall electrolytic conductivity detector (HECD) or a mass spectrometer (MS).
Personal sampling for Aroclors 1242 and 1254 can be accomplished utilizing the National
Institute for Occupational Safety and Health (NIOSH) 5503 method. Samples are collected
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utilizing a sampling train consisting of a 13 mm glass fiber filter followed by a solid sorbent tube
containing deactivated Florisil. Analysis of the samples is performed using GC/ECD.[ 74 ]
Analysis should be done by a certified laboratory, such as those accredited under the AIHA
Industrial Hygiene Laboratory Accreditation Program.[75]
11.0

REMEDIATION

The EPA published the findings of a literature review of remediation methods for PCBs and
PCB-containing building materials in January 2012.[8] PCB remediation is broadly defined as
removing PCB sources from buildings, removing PCBs from building materials, or limiting their
migration or release from sources in buildings. PCB remediation methods are generally
classified as either abatement or mitigation. The purpose of abatement is to remove or reduce
the amount of PCBs in building materials through physical removal or chemical treatment of
source materials. Mitigation is intended to control human exposures to PCBs by limiting their
release from building materials and accumulation in indoor air and surface dust. Mitigation is
often considered a complement to abatement operations.
11.1

Abatement

Abatement methods include the physical removal of primary and secondary PCB sources by
various manual or mechanical means and chemical treatment or decontamination techniques to
reduce PCB concentrations in PCB sources. Abatement is considered a permanent solution to
PCB-containing building materials through source removal or reduction of PCB concentrations
in those materials to below the clearance criteria for residual PCBs as defined in 40 CFR Part
761.
Physical removal is the method of choice for primary source materials such as caulk, glazing,
paint, ceiling tiles and other bulk materials. Hand tools are readily available for removal of
various building materials, including utility knives, putty knives, scrapers, ripping chisels and
bush hammers. Manual methods generally generate less dust, waste, noise, vibration and odor
than do mechanical and chemical removal methods. Caulk found on building exteriors is
generally hard and brittle, whereas caulk found in building interiors is often soft and flexible,
making manual removal somewhat less challenging. Mechanical methods are typically used for
other PCB sources such as surfacing materials (e.g., paints, adhesives, etc.). Abrasive blasting
methods include sand, shot, bead, hydro and carbon dioxide (dry ice) blasting. Mechanical
tools, including various hand-held or large-scale grinding, scraping and cutting equipment (e.g.,
scabblers), are generally employed for removal of secondary sources such as brick and
concrete. HEPA-filtered vacuum attachments should be used to contain the dust generated
during mechanical removal activities. Tools and removal methods that produce heat above 212
degrees Fahrenheit may generate gases that contain PCBs and should be avoided.[76]
Chemical treatments of PCB-containing building materials include chemical degradation or
extraction methods intended to reduce the PCB concentration of the source materials.
Commercially available chemical degradation products are typically applied to sources as a
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slurry or paste, covered with an overlying material and left in place for days to weeks for the
chemical reaction to produce less hazardous substances. One dechlorination product has been
reported to reduce PCB concentrations on various surfaces, including steel ship bulkheads,
railroad ballast, soils and bulk oils, by 90 to 99 percent.[8] Its effectiveness on caulks and
painted surfaces is being studied but findings have not yet been made available. Another
chemical degradation method, known as the Activated Metal Treatment System, has been used
on caulk, concrete and painted surfaces and is reportedly more cost-effective on porous
materials such as concrete than building demolition and disposal.[8] Waste materials to be
managed and disposed of include both the spent product and the degradation products.
Chemical extraction and cleaning methods are typically employed as a precursor step to source
encapsulation or as a follow-up step to bulk removal.[8] One commercially available product for
PCB extraction is a water-based solvent with emulsifiers, which has been used on concrete with
varying results. Odor complaints and significant waste streams are reported concerns with the
use of this product.[8] Another chemical extraction method used on brick and concrete is the
EPA-prescribed double wash and rinse procedure (under 40 CFR 761 Subpart S) with detergent
and solvent washes and potable water and solvent rinses. There are several commercially
available degreaser solvents that can be used. Other chemical cleaning methods for removal of
residual PCBs from nonporous surfaces employ solvents such as mineral spirits, kerosene,
diesel and terpene hydrocarbons, in addition to commercially available cleaning agents such as
trisodium phosphate. The EPA study, however, noted that “bleed-back” of oils and PCBs in
concrete occurred within days of chemical cleaning efforts with all solvents used. This finding
was attributed to the capillary rise of the oil in which the PCBs are dissolved.[8]
For leaks involving liquids containing PCBs, such as those found in old fluorescent light ballasts,
the EPA requires special source removal and waste disposal procedures.[4,8] EPA indicates
that building owners should consider proactive replacement of PCB-containing light fixtures as a
cost-saving control measure as compared to the significant costs for PCB clean-up and building
occupant displacement associated with a ballast leak or failure.
If PCBs have contaminated the adjacent soil and concentrations exceed 1 ppm, the soil is
considered PCB remediation waste and is subject to the cleanup and disposal requirements
specified under 40 CFR 761.61. As such, excavation of PCB-contaminated soils that result from
spills or releases from PCB-containing building materials, as well as from improper abatement,
handling and disposal practices, may be required in some instances.
11.2

Mitigation

PCB mitigation is an interim control measure intended to limit PCB release from building
materials, reduce airborne and surface PCB accumulations inside buildings, and minimize
exposure of building occupants to PCB sources. If properly planned and implemented,
mitigation methods may be as effective as permanent controls in the protection of human and
environmental health. Mitigation, which is often a complement to abatement methods, includes
engineering and administrative control measures, which can be employed individually or in
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various combinations. Priorities for mitigation efforts should be based on the material’s PCB
concentration, condition, accessibility and building occupancy. [8,77,78,79]
11.2.1 Engineering Controls
Engineering controls are modifications to the building’s systems and structures that serve to
reduce the exposure potential of building occupants to PCB sources and releases. Engineering
controls in this application include encapsulation, physical barriers (enclosure), ventilation and
air cleaning.
Encapsulation involves covering PCB sources such as caulk, paints and adhesive with an
impermeable film or sealant to reduce the potential for dermal contact and to reduce PCB
release through mechanical disturbance, deterioration (aging) or volatilization.[8,77,78,79]
Encapsulants include tapes, sealants (acrylic, polyurethane and silicone) and epoxy coatings.
Epoxy coatings have been widely used in joints after caulk removal. In an April 2012 publication,
the EPA reported the major findings of its laboratory study of various encapsulating
materials.[80] The report noted that encapsulation was most effective for contaminated surfaces
with low PCB levels (maximum allowable PCB concentration was estimated to be 430 ppm),
that multiple layers of coatings enhance performance, and that encapsulation offers a significant
cost reduction by not removing PCB-contaminated secondary source materials (e.g., brick,
concrete) from buildings. The EPA indicated that the encapsulation of primary sources, such as
old caulk, which contain high PCB concentrations, may not adequately reduce air and surface
PCB concentrations to recommended levels. EPA also cautioned that building owners need to
implement long-term inspection and monitoring plans to ensure encapsulant seals remain intact.
PCBs have been shown to transfer from secondary sources to encapsulating products intended
to inhibit PCB migration. In one reported case, new silicone caulk applied directly to PCBcontaining caulk absorbed the PCBs and reached levels up to 4,200 ppm.[8]
Physical barriers include the use of interior walls, sealants and foam to enclose PCB sources.
Fences have been used to prevent access to exterior PCB-containing building materials.
Geofabrics, clean stone and new landscaping mulch have been used to prevent access to
contaminated soils resulting from disturbance or degradation of exterior PCB-containing building
materials.
Increased building ventilation with outdoor air (greater than 5 air exchanges per hour) has been
shown to reduce PCB concentrations in indoor air.[8] Energy costs due to heating and cooling of
outdoor air may be significant for building owners. The building ventilation system should be
checked to ensure that it is functioning as designed and, if necessary, owners should make
appropriate repairs to increase or improve ventilation. Exhaust fans can be added to improve
removal of air contaminants.
If elevated levels of airborne PCBs are found in a mechanically ventilated building, the
ventilation system should be evaluated to determine if it is contaminated with PCBs. Although it
is unlikely that the ventilation system is the original source of PCB contamination, it could be
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contaminated from other sources of PCBs and be contributing to the overall airborne levels.
Contaminated ventilation systems should be carefully cleaned and, if possible, such cleaning
should be conducted at the same time as the removal of any known sources of PCBs in order to
avoid re-contamination of the system. The use of air cleaners equipped with activated charcoal
filters operating at 400 cubic feet of air per minute (cfm) was shown to be effective in the
reduction of indoor airborne PCB concentrations in one study.[8]
11.2.2 Administrative Controls
Administrative controls involve changes to the use or maintenance of a building that reduce the
magnitude of potential occupant exposure to PCBs or the likelihood of uncontrolled PCB
releases from source materials. Building spaces with low PCB exposure potential (e.g., storage
areas, attics, etc.) or confirmed indoor air concentrations well below established indoor air
targets are good locations for implementation of administrative controls. Special consideration
should be given to vulnerable populations (i.e., young children) to ensure that accessibility and
exposure to primary and secondary PCB sources are prevented.
Operations and maintenance (O&M) plans for residual PCBs in building materials should be a
major component of an overall facility management plan. O&M plans should address PCB
source materials and concentrations, locations, conditions, accessibility, abatement and
mitigation controls in place, inspections, work practices and controls for contacting and cleaning
PCB source materials and the need for additional remediation actions. The O&M plan should
also include provisions for periodic air and surface sampling to assess PCB concentrations and
effectiveness of mitigation controls and awareness training of building occupants.
Management-in-place of PCB-containing building materials can present significant costs to
building owners.[8,79] Prohibited work practices, such as use of compressed air and dry
sweeping and dusting, should be clearly identified in the O&M plans. Building occupants and
workers should be instructed to avoid or minimize direct contact with PCB-containing materials.
For caulk used on windows, walls, columns and other vertical structures that occupants may
contact, metallic tape can be used to isolate the material so that caulk or dust and debris from
the surrounding masonry do not escape. The metallic tape should cover the caulk and
surrounding areas of masonry.
In addition, disintegrating PCB caulk, paints and other coatings may also shed dust that can
contaminate window sills and other nearby surfaces. Best management practices should be
developed for dealing with dust, including:
o

Frequent cleaning to reduce dust and residue inside buildings;

o

Using wet or damp cloths and/or mops to clean surfaces;

o

Using vacuums equipped with high efficiency particulate air (HEPA) filters;

o

Do not dry sweep and minimize the use of dusters;

o

Wear the appropriate protective clothing when conducting this cleanup;
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o

Dispose of all cleanup materials (mops, rags, filters, water, etc.) in accordance
with all federal, state, and county regulations; and

o

Wash hands and face with soap and water after cleaning, and before eating or
drinking.

Remediation Work Plans

U.S. EPA PCB regulations require that a work plan be prepared prior to starting any PCB
remediation action in a building. [4] The self-implementing procedures required by the EPA for
removal or cleanup of PCB-contaminated building materials require notification and submission
of a work plan to the EPA at least 30 days prior to the site cleanup under 40 CFR 761.61. The
plan must include description of abatement and mitigation activities, proposed cleanup levels,
removal and abatement procedures, verification sampling procedures, waste storage and
handling procedures and disposal options.
As previously stated in this paper, building owners should also confirm the presence of asbestos
and lead in the suspect or identified PCB-containing building materials. Work plans should
identify the additional hazardous materials and contractor workers must meet OSHA, state and
local requirements for abatement of these materials.
A California study evaluated the potential impacts of PCB-containing caulks and sealants
released into storm water runoff during building demolition and renovation projects and a Model
Implementation Process has been initially proposed to establish a regulatory process to manage
PCBs in caulks and sealants to protect water quality.[76] Similar to building demolition projects
involving asbestos and lead, industrial hygienists can play a significant role in community and
environmental protection through careful planning and oversight of work area containment, dust
suppression methods, site erosion and sediment controls and protection of storm water drains.
11.4

Evaluation of Remediation Methods

The EPA’s PCB regulations (40 CFR 761) do not specify a schedule for the determination of
PCB-containing materials as waste or for the remediation of PCB waste.[4] Building owners are
thus able to evaluate site-specific conditions, various remediation options, establish practical
remediation goals and select the remediation strategy that is most appropriate for their buildings
with PCB-containing materials. Building owners should also understand that interim control of
identified PCB releases to the environment may be required while options for permanent
remedies are evaluated. Significant costs are associated with managing PCBs in place.
Several studies have demonstrated that the available abatement and mitigation methods are
effective for complying with current PCB regulations, especially when multiple methods are used
concurrently for PCB hazard reduction. Additional factors that may drive a remedial response
are PCB concentrations in indoor air and surface dust, regardless of the PCB content of the
building materials themselves.
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Post-Remediation Verification

40 CFR 761.79 provides for measurement-based methods (i.e., post-remediation wipe sampling
and analysis) as well as performance-based methods (e.g., incineration). These may proceed
without prior EPA approval. However, if an alternate remediation strategy is to be used, then
EPA approval must be obtained. This rule defines decontamination standards and procedures
for the removal of PCBs from a variety of media, such as water, concrete, organic liquids, and
non-porous surfaces. For the built/building environment, there are two specific applications:
concrete and non-porous surfaces covered with a porous surface, such as paint or coatings on
metals.
40 CFR 761.79(f) requires confirmatory sampling per Subpart P, which addresses sampling of
wastes for proper disposal methods under 761.61(a)(6), as well as decontamination verification
under 761.79 (b)(3).
Decontamination verification for abated non-porous surfaces that were covered with PCB paint
or caulk is a visual examination followed by a standard wipe test per 761.123. A variety of
solvents may be selected for sampling, but many of these solvents are flammable and have
their own toxicity concerns. A wipe sample is typically acquired from a 10 centimeter by 10
centimeter surface area; sufficient numbers of samples must be collected to meet statistical
treatments.
11.6

Personal Protective Equipment

Workers performing PCB remediation normally wear disposable whole body clothing and shoe
covers, respiratory protection, chemical-resistant gloves, and safety glasses or protective
goggles to protect against inhalation and dermal exposure to PCBs.
As noted above, in addition to PCBs, caulking and other construction materials may also contain
lead or asbestos. In many cases remediation should proceed in a manner similar to lead or
asbestos removal. While there are no nationally recognized PCB removal certifications, facility
owners may want to consider utilizing contractors with AHERA or RRP abatement certifications.


Respirators – air purifying respirators are typically worn by workers during remediation
work. While half facepiece respirators may be acceptable based on the exposure levels,
some employers prefer to use full facepiece respirators or powered air purifying
respirators (PAPRs). Both full-facepiece (with quantitative fit testing) and PAPRs provide
higher assigned protection factors than half-facepiece respirators. The full-facepiece
respirator also provides eye protection and additional skin protection by covering the
whole face. PAPRs, when used with hoods or helmets, can protect the entire head, neck
and shoulder area. Depending on the system, PAPRs may offer additional advantages,
such as allowing limited facial hair and waiving of fit-testing. PCBs are primarily a
particulate hazard and a P95 filter would be appropriate. However, a P100 filter is
required if lead or asbestos co-exists with the PCBs. Therefore, employers may want to
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consider routine use of P100 filters as a precaution in case previously unidentified
asbestos or lead is encountered during remediation. At this time, PAPRs use only the
high efficiency (HE) designation – not 95 or 100 designations.
PCBs may also be present in a vapor form, especially if the material has been heated. If
there is any possibility of a vapor phase being present, employers should use a
combination P100/organic vapor cartridge.[81] A respiratory protection program that
complies with the requirements of 29 CFR Part 1910.134 must be established.
Respirator users must understand and follow the respirator user instructions and any
other manufacturer’s recommendations and warnings.


Worker protective clothing (WPC) – Full-body WPC should be worn during remediation
to minimize skin contact and also to minimize the risk of bringing contaminated clothing
back to the worker’s home. Employers may want to look for WPC that meets the
requirements of EN ISO 13982-1 Type 5 - Protective Clothing for Use against Solid
Particles or ANSI/ISEA 103-2010 American National Standard for Classification and
Performance Requirements for Chemical Protective Clothing.[82,83]



Gloves – PCBs may be absorbed to a significant extent through the skin. Therefore,
chemical-protective gloves should be worn when handling PCB-contaminated material.
EPA suggests using gloves made of nitrile butadiene rubber.[81] Butyl rubber or
neoprene may also offer sufficient protection for incidental contact during
remediation.[84] The glove manufacturer should always be consulted to determine the
best product for the specific tasks and expected exposures.

11.7

Training

Training for remediation workers should, at a minimum, include the following:









Location of PCB-containing materials in the worksite;
Hazard Communication training for PCBs that, at a minimum, meets the requirements of
29 CFR 1910.1200 and the importance of minimizing worker exposure (both inhalation
and skin exposure);
Other hazardous materials (e.g. lead, asbestos) that may also be present. If present,
training and other requirements per 29 CFR 1926.62 and 29 CFR 1926.1101 must be
followed;
Engineering controls that will be used to minimize release of PCB materials (e.g. HEPA
filtered vacuums, wet methods, local exhausted power tools);
Eating, drinking and smoking are prohibited during handling of PCB materials and not
allowed until required decontamination has been completed; and
Proper inspection, use, cleaning, and storage of PPE per the manufacturer’s user
instructions. Eating, drinking and smoking are prohibited during handling of PCB
materials and not allowed until required decontamination has been completed.
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Waste Disposal

11.8.1 PCB Waste Categories
Under 40 CFR 761.3, a building material that is identified as an unauthorized use of PCBs and
designated for disposal must be properly classified as either a PCB Bulk Product Waste or a
PCB Remediation Waste. Materials that were “manufactured, coated or serviced with PCBs”
and that contain 50 ppm or greater PCBs are subject to the requirements for PCB Bulk Product
Waste. Primary sources of PCB-containing building materials such as caulks, glazing, mastics,
sealants, paints and surface coatings are generally classified as PCB Bulk Product Waste.
On October 24, 2012, EPA issued a memorandum on the proposed reinterpretation of the PCB
Bulk Product Waste definition noting that building materials (i.e., substrates) that are “coated or
serviced with PCB Bulk Product Waste (e.g., caulk, paint, mastic, sealants) at the time of
designation of disposal are to be managed as a PCB bulk product waste, even if the PCBs have
migrated from the overlying bulk product waste into the substrate, provided there is no other
source of PCB contamination on or in the substrate.”[85] If the bulk product waste has been
removed or separated (no longer coated or serviced) from the substrate at the time of
designation for disposal and the substrate is contaminated with PCBs that have migrated from
the bulk product waste, the substrate would be considered a PCB remediation waste. EPA
recommends that the building owner document in the abatement plan the decision to designate
building materials as bulk product waste at the time of designation for disposal. EPA notes that
this proposed reinterpretation will allow for prompt PCB removal and disposal and thereby
reduce potential exposure of building occupants and workers. EPA notes that it received no
opposition in public comments to its proposed reinterpretation.
Secondary sources or materials that contain PCBs as a result of a release from primary sources
are subject to the PCB Remediation Waste regulations. These include building materials such
as brick, concrete and other building materials contaminated by PCB spills, waste materials
from clean-up activities, and contaminated soil. Leaching is considered by EPA to be a release
of PCBs.
11.8.2 Waste Disposal
Disposal options for PCB Bulk Product Waste (40 CFR Part 761.62) include performance-based
disposal by landfill, incineration or decontamination at a Resource Conservation and Recovery
Act (RCRA) permitted facility. EPA may also approve a risk-based disposal method if it can be
demonstrated that it will not pose an unreasonable risk of injury to health or the environment.
EPA regulations allow PCB Remediation Waste to be managed according to a method that is
termed self-implementing onsite clean-up and disposal. This disposal option allows residual
levels of PCB Remediation Waste to remain in a building, the amount depending on the use
characteristics of the property and the disposition of the PCBs: high occupancy (e.g., school
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classroom, plant assembly line, cafeteria) versus low occupancy (e.g., non-office space in a
warehouse or electrical equipment vault) areas; bulk concentrations versus surface loading
levels; and unrestricted land use versus a deed restriction. The surface clearance criteria for
PCB Remediation Waste for a nonporous surface is less than or equal to ten micrograms of
PCBs per 100 square centimeters (µg/100 cm2) in a high-occupancy area and less than 100
µg/100 cm2 for a low-occupancy area.[4,8] The clearance criteria for PCB Remediation Waste
for a bulk or porous material is less than or equal to one ppm in a high-occupancy area and less
than or equal to 25 ppm in a low-occupancy area.[4,8]
12.0

DISCUSSION

Review of the current state of PCB knowledge has identified critical information gaps pertaining
to the health risks that PCBs in the built environment may pose to occupants and workers.
While it is beyond the scope of this white paper to quantify the risk of PCBs ingested from
contaminated food, as compared to the risk associated with exposure to PCBs arising from the
built environment, it should be kept in mind that most of the human PCB exposure historically
has been mainly through the ingestion of contaminated food or from occupational exposures
(e.g. manufacturing PCB-containing components, etc.). The health risks posed by PCBs in the
built environment are not well understood. Hence, improved exposure assessments in the built
environment are necessary to further understand the short and long-term risks to building
occupants, building maintenance and construction personnel from PCB-containing construction
materials.
Some of the potentially significant data gaps identified include:


The paucity of exposure assessment data with congener-specific identification and
resulting exposure profiles to building occupants, maintenance personnel and
construction workers. In addition, there is inconsistency within published studies on the
selection of congeners studied; some use methods of analysis that provide results for
prescribed congeners, while others attempt to link source-confirmed congeners to air
sampling data. There is a need for standardized approaches to the selection of
congeners under study in the built environment, whether for biological, environmental or
structural characterization purposes.



There is a lack of complete exposure profiles across the variety of building types, with
consideration of the populations occupying them. Few of the studies cited reported on
occupancy characteristics of the populations (i.e., times of day and days of week the
building was occupied, etc.), which would serve to refine risk and exposure assessments
from source materials.



In the United States, current TSCA regulations do not require identification of PCBcontaining building materials, unless activities are planned that may generate PCB
wastes (i.e. renovation or demolition activities). Additionally, very few international
regulations have, as a starting point, an obligation to identify and confirm open sources
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of PCBs. As a result, many environments with PCB exposures go unrecognized, or are
mischaracterized because the primary exposure sources may be unidentified (such as
assessing airborne concentrations of PCBs released from PCB-containing caulk when
concrete in the same room had previously been contaminated from leaking light
ballasts). Thorough hazard identification should always be the first step prior to
determining risk to the occupants.


Currently prescribed respiratory protection levels for abatement/remediation/mitigation
activities do not appear to suitably address work involving PCBs in their vapor phase.
The use of air-purifying respiratory protection equipped with combination HEPA/organic
vapor cartridges is recommended.



Non-legacy PCBs in pigments continue to be produced. Such pigments may have
consequences related to human health and the environment through contaminated
drinking water or bioaccumulation in the food chain.

13.0

CONCLUSION

This white paper has reviewed and summarized the current scientific body of knowledge with
respect to the hazard identification, exposure assessment and risk management related to
PCBs in the built environment. In support of AIHA’s current strategic plan, and based on a
review of the issue, the authors call attention to the following needs for the development of
public policy based on sound science. AIHA can assist in this endeavor by:
1. Promoting the need for additional scientific research into the relative exposure risks
posed by PCB-containing building materials to building occupants, maintenance and
construction personnel; and
2. Encouraging the collection of exposure assessment data by the industrial hygiene and
scientific community to confirm and verify the extent of any such risks.
Development of PCB exposure assessment profiles for building occupants, as well as
maintenance and construction personnel, can lead to a better understanding of the populations
most at risk from PCBs in building materials. Risk assessment analyses, based on more
comprehensive exposure data, could then serve as the technical basis for possible regulatory
changes to help ensure that human health and the environment are appropriately protected
based on an improved understanding of the role that PCBs in building materials may play in the
overall exposure risk from PCBs (i.e. dietary versus building environment exposures).
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Appendix A: PCB Species by Congener Number

IUPAC Name

BZ Congener
Number

CASRN

Biphenyl

0

92-52-4

2-Chlorobiphenyl

1

2051-60-7

CP1

3-Chlorobiphenyl

2

2051-61-8

CP0

4-Chlorobiphenyl

3

2051-62-9

CP0

2,2'-Dichlorobiphenyl

4

13029-08-8

2,3-Dichlorobiphenyl

5

16605-91-7

CP1

2,3'-Dichlorobiphenyl

6

25569-80-6

CP1

2,4-Dichlorobiphenyl

7

33284-50-3

CP1

2,4'-Dichlorobiphenyl

8

34883-43-7

CP1

2,5-Dichlorobiphenyl

9

34883-39-1

CP1

2,6-Dichlorobiphenyl

10

33146-45-1

3,3'-Dichlorobiphenyl

11

2050-67-1

CP0, 2M

3,4-Dichlorobiphenyl

12

2974-92-7

CP0

3,4'-Dichlorobiphenyl

13

2974-90-5

CP0

3,5-Dichlorobiphenyl

14

34883-41-5

CP0, 2M

4,4'-Dichlorobiphenyl

15

2050-68-2

CP0, PP

2,2',3-Trichlorobiphenyl

16

38444-78-9

2,2',4-Trichlorobiphenyl

17

37680-66-3

2,2',5-Trichlorobiphenyl

18

37680-65-2

2,2',6-Trichlorobiphenyl

19

38444-73-4

2,3,3'-Trichlorobiphenyl

20

38444-84-7
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IUPAC Name

BZ Congener
Number

CASRN

2,3,4-Trichlorobiphenyl

21

55702-46-0

CP1

2,3,4'-Trichlorobiphenyl

22

38444-85-8

CP1

2,3,5-Trichlorobiphenyl

23

55720-44-0

CP1, 2M

2,3,6-Trichlorobiphenyl

24

55702-45-9

2,3',4-Trichlorobiphenyl

25

55712-37-3

CP1

2,3',5-Trichlorobiphenyl

26

38444-81-4

CP1, 2M

2,3',6-Trichlorobiphenyl

27

38444-76-7

2,4,4'-Trichlorobiphenyl

28

7012-37-5

CP1, PP

2,4,5-Trichlorobiphenyl

29

15862-07-4

CP1

2,4,6-Trichlorobiphenyl

30

35693-92-6

2,4',5-Trichlorobiphenyl

31

16606-02-3

2,4',6-Trichlorobiphenyl

32

38444-77-8

2,3',4'-Trichlorobiphenyl

33

38444-86-9

CP1

2,3',5'-Trichlorobiphenyl

34

37680-68-5

CP1, 2M

3,3',4-Trichlorobiphenyl

35

37680-69-6

CP0, 2M

3,3',5-Trichlorobiphenyl

36

38444-87-0

CP0, 2M

3,4,4'-Trichlorobiphenyl

37

38444-90-5

CP0, PP

3,4,5-Trichlorobiphenyl

38

53555-66-1

CP0, 2M

3,4',5-Trichlorobiphenyl

39

38444-88-1

CP0, 2M

2,2',3,3'-Tetrachlorobiphenyl

40

38444-93-8

4CL, 2M

2,2',3,4-Tetrachlorobiphenyl

41

52663-59-9

4CL

2,2',3,4'-Tetrachlorobiphenyl

42

36559-22-5

4CL
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IUPAC Name

BZ Congener
Number

CASRN

2,2',3,5-Tetrachlorobiphenyl

43

70362-46-8

4CL, 2M

2,2',3,5'-Tetrachlorobiphenyl

44

41464-39-5

4CL, 2M

2,2',3,6-Tetrachlorobiphenyl

45

70362-45-7

4CL

2,2',3,6'-Tetrachlorobiphenyl

46

41464-47-5

4CL

2,2',4,4'-Tetrachlorobiphenyl

47

2437-79-8

4CL, PP

2,2',4,5-Tetrachlorobiphenyl

48

70362-47-9

4CL

2,2',4,5'-Tetrachlorobiphenyl

49

41464-40-8

4CL

2,2',4,6-Tetrachlorobiphenyl

50

62796-65-0

4CL

2,2',4,6'-Tetrachlorobiphenyl

51

68194-04-7

4CL

2,2',5,5'-Tetrachlorobiphenyl

52

35693-99-3

4CL, 2M

2,2',5,6'-Tetrachlorobiphenyl

53

41464-41-9

4CL

2,2',6,6'-Tetrachlorobiphenyl

54

15968-05-5

4CL

2,3,3',4-Tetrachlorobiphenyl

55

74338-24-2

CP1, 4CL, 2M

2,3,3',4'-Tetrachlorobiphenyl

56

41464-43-1

CP1, 4CL, 2M

2,3,3',5-Tetrachlorobiphenyl

57

70424-67-8

CP1, 4CL, 2M

2,3,3',5'-Tetrachlorobiphenyl

58

41464-49-7

CP1, 4CL, 2M

2,3,3',6-Tetrachlorobiphenyl

59

74472-33-6

4CL, 2M

2,3,4,4'-Tetrachlorobiphenyl

60

33025-41-1

CP1, 4CL, PP

2,3,4,5-Tetrachlorobiphenyl

61

33284-53-6

CP1, 4CL, 2M

2,3,4,6-Tetrachlorobiphenyl

62

54230-22-7

4CL

2,3,4',5-Tetrachlorobiphenyl

63

74472-34-7

CP1, 4CL, 2M

2,3,4',6-Tetrachlorobiphenyl

64

52663-58-8

4CL
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IUPAC Name

BZ Congener
Number

CASRN

2,3,5,6-Tetrachlorobiphenyl

65

33284-54-7

4CL, 2M

2,3',4,4'-Tetrachlorobiphenyl

66

32598-10-0

CP1, 4CL, PP

2,3',4,5-Tetrachlorobiphenyl

67

73575-53-8

CP1, 4CL, 2M

2,3',4,5'-Tetrachlorobiphenyl

68

73575-52-7

CP1, 4CL, 2M

2,3',4,6-Tetrachlorobiphenyl

69

60233-24-1

4CL

2,3',4',5-Tetrachlorobiphenyl

70

32598-11-1

CP1, 4CL, 2M

2,3',4',6-Tetrachlorobiphenyl

71

41464-46-4

4CL

2,3',5,5'-Tetrachlorobiphenyl

72

41464-42-0

CP1, 4CL, 2M

2,3',5',6-Tetrachlorobiphenyl

73

74338-23-1

4CL, 2M

2,4,4',5-Tetrachlorobiphenyl

74

32690-93-0

CP1, 4CL, PP

2,4,4',6-Tetrachlorobiphenyl

75

32598-12-2

4CL, PP

2,3',4',5'-Tetrachlorobiphenyl

76

70362-48-0

CP1, 4CL, 2M

3,3',4,4'-Tetrachlorobiphenyl

77

32598-13-3

CP0, 4CL, PP, 2M

3,3',4,5-Tetrachlorobiphenyl

78

70362-49-1

CP0, 4CL, 2M

3,3',4,5'-Tetrachlorobiphenyl

79

41464-48-6

CP0, 4CL, 2M

3,3',5,5'-Tetrachlorobiphenyl

80

33284-52-5

CP0, 4CL, 2M

3,4,4',5-Tetrachlorobiphenyl

81

70362-50-4

CP0, 4CL, PP, 2M

2,2',3,3',4-Pentachlorobiphenyl

82

52663-62-4

4CL, 2M

2,2',3,3',5-Pentachlorobiphenyl

83

60145-20-2

4CL, 2M

2,2',3,3',6-Pentachlorobiphenyl

84

52663-60-2

4CL, 2M

2,2',3,4,4'-Pentachlorobiphenyl

85

65510-45-4

4CL, PP

2,2',3,4,5-Pentachlorobiphenyl

86

55312-69-1

4CL, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,2',3,4,5'-Pentachlorobiphenyl

87

38380-02-8

4CL, 2M

2,2',3,4,6-Pentachlorobiphenyl

88

55215-17-3

4CL

2,2',3,4,6'-Pentachlorobiphenyl

89

73575-57-2

4CL

2,2',3,4',5-Pentachlorobiphenyl

90

68194-07-0

4CL, 2M

2,2',3,4',6-Pentachlorobiphenyl

91

68194-05-8

4CL

2,2',3,5,5'-Pentachlorobiphenyl

92

52663-61-3

4CL, 2M

2,2',3,5,6-Pentachlorobiphenyl

93

73575-56-1

4CL, 2M

2,2',3,5,6'-Pentachlorobiphenyl

94

73575-55-0

4CL, 2M

2,2',3,5',6-Pentachlorobiphenyl

95

38379-99-6

4CL, 2M

2,2',3,6,6'-Pentachlorobiphenyl

96

73575-54-9

4CL

2,2',3,4',5'-Pentachlorobiphenyl

97

41464-51-1

4CL, 2M

2,2',3,4',6'-Pentachlorobiphenyl

98

60233-25-2

4CL

2,2',4,4',5-Pentachlorobiphenyl

99

38380-01-7

4CL, PP

2,2',4,4',6-Pentachlorobiphenyl

100

39485-83-1

4CL, PP

2,2',4,5,5'-Pentachlorobiphenyl

101

37680-73-2

4CL, 2M

2,2',4,5,6'-Pentachlorobiphenyl

102

68194-06-9

4CL

2,2',4,5',6-Pentachlorobiphenyl

103

60145-21-3

4CL

2,2',4,6,6'-Pentachlorobiphenyl

104

56558-16-8

4CL

2,3,3',4,4'-Pentachlorobiphenyl

105

32598-14-4

CP1, 4CL, PP, 2M

2,3,3',4,5-Pentachlorobiphenyl

106

70424-69-0

CP1, 4CL, 2M

2,3,3',4',5-Pentachlorobiphenyl

107

70424-68-9

CP1, 4CL, 2M

2,3,3',4,5'-Pentachlorobiphenyl

108

70362-41-3

CP1, 4CL, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,3,3',4,6-Pentachlorobiphenyl

109

74472-35-8

4CL, 2M

2,3,3',4',6-Pentachlorobiphenyl

110

38380-03-9

4CL, 2M

2,3,3',5,5'-Pentachlorobiphenyl

111

39635-32-0

CP1, 4CL, 2M

2,3,3',5,6-Pentachlorobiphenyl

112

74472-36-9

4CL, 2M

2,3,3',5',6-Pentachlorobiphenyl

113

68194-10-5

4CL, 2M

2,3,4,4',5-Pentachlorobiphenyl

114

74472-37-0

CP1, 4CL, PP, 2M

2,3,4,4',6-Pentachlorobiphenyl

115

74472-38-1

4CL, PP

2,3,4,5,6-Pentachlorobiphenyl

116

18259-05-7

4CL, 2M

2,3,4',5,6-Pentachlorobiphenyl

117

68194-11-6

4CL, 2M

2,3',4,4',5-Pentachlorobiphenyl

118

31508-00-6

CP1, 4CL, PP, 2M

2,3',4,4',6-Pentachlorobiphenyl

119

56558-17-9

4CL, PP

2,3',4,5,5'-Pentachlorobiphenyl

120

68194-12-7

CP1, 4CL, 2M

2,3',4,5',6-Pentachlorobiphenyl

121

56558-18-0

4CL, 2M

2,3,3',4',5'-Pentachlorobiphenyl

122

76842-07-4

CP1, 4CL, 2M

2,3',4,4',5'-Pentachlorobiphenyl

123

65510-44-3

CP1, 4CL, PP, 2M

2,3',4',5,5'-Pentachlorobiphenyl

124

70424-70-3

CP1, 4CL, 2M

2,3',4',5',6-Pentachlorobiphenyl

125

74472-39-2

4CL, 2M

3,3',4,4',5-Pentachlorobiphenyl

126

57465-28-8

CP0, 4CL, PP, 2M

3,3',4,5,5'-Pentachlorobiphenyl

127

39635-33-1

CP0, 4CL, 2M

2,2',3,3',4,4'-Hexachlorobiphenyl

128

38380-07-3

4CL, PP, 2M

2,2',3,3',4,5-Hexachlorobiphenyl

129

55215-18-4

4CL, 2M

2,2',3,3',4,5'-Hexachlorobiphenyl

130

52663-66-8

4CL, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,2',3,3',4,6-Hexachlorobiphenyl

131

61798-70-7

4CL, 2M

2,2',3,3',4,6'-Hexachlorobiphenyl

132

38380-05-1

4CL, 2M

2,2',3,3',5,5'-Hexachlorobiphenyl

133

35694-04-3

4CL, 2M

2,2',3,3',5,6-Hexachlorobiphenyl

134

52704-70-8

4CL, 2M

2,2',3,3',5,6'-Hexachlorobiphenyl

135

52744-13-5

4CL, 2M

2,2',3,3',6,6'-Hexachlorobiphenyl

136

38411-22-2

4CL, 2M

2,2',3,4,4',5-Hexachlorobiphenyl

137

35694-06-5

4CL, PP, 2M

2,2',3,4,4',5'-Hexachlorobiphenyl

138

35065-28-2

4CL, PP, 2M

2,2',3,4,4',6-Hexachlorobiphenyl

139

56030-56-9

4CL, PP

2,2',3,4,4',6'-Hexachlorobiphenyl

140

59291-64-4

4CL, PP

2,2',3,4,5,5'-Hexachlorobiphenyl

141

52712-04-6

4CL, 2M

2,2',3,4,5,6-Hexachlorobiphenyl

142

41411-61-4

4CL, 2M

2,2',3,4,5,6'-Hexachlorobiphenyl

143

68194-15-0

4CL, 2M

2,2',3,4,5',6-Hexachlorobiphenyl

144

68194-14-9

4CL, 2M

2,2',3,4,6,6'-Hexachlorobiphenyl

145

74472-40-5

4CL

2,2',3,4',5,5'-Hexachlorobiphenyl

146

51908-16-8

4CL, 2M

2,2',3,4',5,6-Hexachlorobiphenyl

147

68194-13-8

4CL, 2M

2,2',3,4',5,6'-Hexachlorobiphenyl

148

74472-41-6

4CL, 2M

2,2',3,4',5',6-Hexachlorobiphenyl

149

38380-04-0

4CL, 2M

2,2',3,4',6,6'-Hexachlorobiphenyl

150

68194-08-1

4CL

2,2',3,5,5',6-Hexachlorobiphenyl

151

52663-63-5

4CL, 2M

2,2',3,5,6,6'-Hexachlorobiphenyl

152

68194-09-2

4CL, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,2',4,4',5,5'-Hexachlorobiphenyl

153

35065-27-1

4CL, PP, 2M

2,2',4,4',5,6'-Hexachlorobiphenyl

154

60145-22-4

4CL, PP

2,2',4,4',6,6'-Hexachlorobiphenyl

155

33979-03-2

4CL, PP

2,3,3',4,4',5-Hexachlorobiphenyl

156

38380-08-4

CP1, 4CL, PP, 2M

2,3,3',4,4',5'-Hexachlorobiphenyl

157

69782-90-7

CP1, 4CL, PP, 2M

2,3,3',4,4',6-Hexachlorobiphenyl

158

74472-42-7

4CL, PP, 2M

2,3,3',4,5,5'-Hexachlorobiphenyl

159

39635-35-3

CP1, 4CL, 2M

2,3,3',4,5,6-Hexachlorobiphenyl

160

41411-62-5

4CL, 2M

2,3,3',4,5',6-Hexachlorobiphenyl

161

74472-43-8

4CL, 2M

2,3,3',4',5,5'-Hexachlorobiphenyl

162

39635-34-2

CP1, 4CL, 2M

2,3,3',4',5,6-Hexachlorobiphenyl

163

74472-44-9

4CL, 2M

2,3,3',4',5',6-Hexachlorobiphenyl

164

74472-45-0

4CL, 2M

2,3,3',5,5',6-Hexachlorobiphenyl

165

74472-46-1

4CL, 2M

2,3,4,4',5,6-Hexachlorobiphenyl

166

41411-63-6

4CL, PP, 2M

2,3',4,4',5,5'-Hexachlorobiphenyl

167

52663-72-6

CP1, 4CL, PP, 2M

2,3',4,4',5',6-Hexachlorobiphenyl

168

59291-65-5

4CL, PP, 2M

3,3',4,4',5,5'-Hexachlorobiphenyl

169

32774-16-6

CP0, 4CL, PP, 2M

2,2',3,3',4,4',5-Heptachlorobiphenyl

170

35065-30-6

4CL, PP, 2M

2,2',3,3',4,4',6-Heptachlorobiphenyl

171

52663-71-5

4CL, PP, 2M

2,2',3,3',4,5,5'-Heptachlorobiphenyl

172

52663-74-8

4CL, 2M

2,2',3,3',4,5,6-Heptachlorobiphenyl

173

68194-16-1

4CL, 2M

2,2',3,3',4,5,6'-Heptachlorobiphenyl

174

38411-25-5

4CL, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,2',3,3',4,5',6-Heptachlorobiphenyl

175

40186-70-7

4CL, 2M

2,2',3,3',4,6,6'-Heptachlorobiphenyl

176

52663-65-7

4CL, 2M

2,2',3,3',4,5',6'-Heptachlorobiphenyl

177

52663-70-4

4CL, 2M

2,2',3,3',5,5',6-Heptachlorobiphenyl

178

52663-67-9

4CL, 2M

2,2',3,3',5,6,6'-Heptachlorobiphenyl

179

52663-64-6

4CL, 2M

2,2',3,4,4',5,5'-Heptachlorobiphenyl

180

35065-29-3

4CL, PP, 2M

2,2',3,4,4',5,6-Heptachlorobiphenyl

181

74472-47-2

4CL, PP, 2M

2,2',3,4,4',5,6'-Heptachlorobiphenyl

182

60145-23-5

4CL, PP, 2M

2,2',3,4,4',5',6-Heptachlorobiphenyl

183

52663-69-1

4CL, PP, 2M

2,2',3,4,4',6,6'-Heptachlorobiphenyl

184

74472-48-3

4CL, PP

2,2',3,4,5,5',6-Heptachlorobiphenyl

185

52712-05-7

4CL, 2M

2,2',3,4,5,6,6'-Heptachlorobiphenyl

186

74472-49-4

4CL, 2M

2,2',3,4',5,5',6-Heptachlorobiphenyl

187

52663-68-0

4CL, 2M

2,2',3,4',5,6,6'-Heptachlorobiphenyl

188

74487-85-7

4CL, 2M

2,3,3',4,4',5,5'-Heptachlorobiphenyl

189

39635-31-9

CP1, 4CL, PP, 2M

2,3,3',4,4',5,6-Heptachlorobiphenyl

190

41411-64-7

4CL, PP, 2M

2,3,3',4,4',5',6-Heptachlorobiphenyl

191

74472-50-7

4CL, PP, 2M

2,3,3',4,5,5',6-Heptachlorobiphenyl

192

74472-51-8

4CL, 2M

2,3,3',4',5,5',6-Heptachlorobiphenyl

193

69782-91-8

4CL, 2M

2,2',3,3',4,4',5,5'-Octachlorobiphenyl

194

35694-08-7

4CL, PP, 2M

2,2',3,3',4,4',5,6-Octachlorobiphenyl

195

52663-78-2

4CL, PP, 2M

2,2',3,3',4,4',5,6'-Octachlorobiphenyl

196

42740-50-1

4CL, PP, 2M
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IUPAC Name

BZ Congener
Number

CASRN

2,2',3,3',4,4',6,6'-Octachlorobiphenyl

197

33091-17-7

4CL, PP, 2M

2,2',3,3',4,5,5',6-Octachlorobiphenyl

198

68194-17-2

4CL, 2M

2,2',3,3',4,5,5',6'-Octachlorobiphenyl

199

52663-75-9

4CL, 2M

2,2',3,3',4,5,6,6'-Octachlorobiphenyl

200

52663-73-7

4CL, 2M

2,2',3,3',4,5',6,6'-Octachlorobiphenyl

201

40186-71-8

4CL, 2M

2,2',3,3',5,5',6,6'-Octachlorobiphenyl

202

2136-99-4

4CL, 2M

2,2',3,4,4',5,5',6-Octachlorobiphenyl

203

52663-76-0

4CL, PP, 2M

2,2',3,4,4',5,6,6'-Octachlorobiphenyl

204

74472-52-9

4CL, PP, 2M

2,3,3',4,4',5,5',6-Octachlorobiphenyl

205

74472-53-0

4CL, PP, 2M

2,2',3,3',4,4',5,5',6-Nonachlorobiphenyl

206

40186-72-9

4CL, PP, 2M

2,2',3,3',4,4',5,6,6'-Nonachlorobiphenyl

207

52663-79-3

4CL, PP, 2M

2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl

208

52663-77-1

4CL, 2M

Decachlorobiphenyl

209

2051-24-3

4CL, PP, 2M

Descriptors

IUPAC – International Union of Pure and Applied Chemistry
BZ Congener Number – the congener numbering is identical to that published by K.
Ballschmiter, R. Bacher, A. Mennel, R. Fischer, U. Riehle, and M. Swerev. Determination of
chlorinated biphenyls, chlorinated ibenzodioxins, and chlorinated dibenzofurans by GC-MS. J.
High Resol. Chromatogr. 15:260-270. April 1992.
CASRN – Chemical Abstracts Service Registry Number
CP0 / CP1 - These 68 coplanar congeners fall into one of two groups. The first group of 20
congeners consists of those with chlorine substitution at none of the ortho positions on the
biphenyl backbone and are referred to as CP0 or non-ortho congeners. The second group of 48
congeners includes those with chlorine substitution at only one of the ortho positions and are
referred to as CP1 or mono-ortho congeners.
4CL - These 169 congeners have a total of four or more chlorine substituents, regardless of
position.
PP - These 54 congeners have both para positions chlorinated.
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2M - These 140 congeners have two or more of the meta positions chlorinated.
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